2A、2B和2M型血管性血友病中血管性血友病因子胶原结合试验 - Suppr

Suppr

超能文献

von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.

作者信息

Baronciani L, Federici A B, Cozzi G, Canciani M T, Mannucci P M

出版信息

J Thromb Haemost. 2006 Sep;4(9):2088-90. doi: 10.1111/j.1538-7836.2006.02069.x.

DOI:10.1111/j.1538-7836.2006.02069.x

PMID:16961623

Abstract

摘要

相似文献

von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.

J Thromb Haemost. 2006 Sep;4(9):2088-90. doi: 10.1111/j.1538-7836.2006.02069.x.

Molecular genetics of type 2 von Willebrand disease.

Int J Hematol. 2002 Jan;75(1):9-18. doi: 10.1007/BF02981973.

Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease.

J Thromb Haemost. 2007 Feb;5(2):282-8. doi: 10.1111/j.1538-7836.2007.02349.x. Epub 2006 Dec 7.

von Willebrand disease, type 2B: A diagnosis more elusive than previously thought.

Thromb Haemost. 2008 Mar;99(3):630-1; author reply 632-3. doi: 10.1160/TH07-12-0758.

Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.

J Thromb Haemost. 2007 Feb;5(2):321-8. doi: 10.1111/j.1538-7836.2007.02296.x. Epub 2006 Nov 1.

Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.

Acta Haematol. 2009;121(2-3):145-53. doi: 10.1159/000214855. Epub 2009 Jun 8.

The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.

J Thromb Haemost. 2006 Feb;4(2):417-25. doi: 10.1111/j.1538-7836.2006.01742.x.

Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.

Acta Haematol. 2009;121(2-3):154-66. doi: 10.1159/000214856. Epub 2009 Jun 8.

[Information on von Willebrand disease].

Rinsho Byori. 1997 Oct;45(10):942-50.

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?

Br J Haematol. 2001 Mar;112(3):578-83. doi: 10.1046/j.1365-2141.2001.02597.x.

引用本文的文献

Ratio of Von Willebrand Collagen Binding Assay and Von Willebrand Antigen Can Predict Multimer Size in Von Willebrand Disease.

Haemophilia. 2025 May;31(3):450-457. doi: 10.1111/hae.70025. Epub 2025 Mar 7.

Structure-resolved dynamics of type 2M von Willebrand disease.

J Thromb Haemost. 2025 Apr;23(4):1215-1228. doi: 10.1016/j.jtha.2024.12.026. Epub 2025 Jan 3.

New advances in the diagnosis of von Willebrand disease.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):596-600. doi: 10.1182/hematology.2019000064.

The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.

J Mol Biol. 2017 Jan 6;429(1):32-47. doi: 10.1016/j.jmb.2016.11.014. Epub 2016 Nov 24.

Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity.

Int J Lab Hematol. 2013 Apr;35(2):170-6. doi: 10.1111/ijlh.12019. Epub 2012 Oct 29.

Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.

J Thromb Haemost. 2012 May;10(5):940-50. doi: 10.1111/j.1538-7836.2012.04675.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.

作者信息

Baronciani L, Federici A B, Cozzi G, Canciani M T, Mannucci P M

出版信息

J Thromb Haemost. 2006 Sep;4(9):2088-90. doi: 10.1111/j.1538-7836.2006.02069.x.

DOI:10.1111/j.1538-7836.2006.02069.x

PMID:16961623

Abstract

摘要

相似文献

von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.

J Thromb Haemost. 2006 Sep;4(9):2088-90. doi: 10.1111/j.1538-7836.2006.02069.x.

Molecular genetics of type 2 von Willebrand disease.

Int J Hematol. 2002 Jan;75(1):9-18. doi: 10.1007/BF02981973.

Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease.

J Thromb Haemost. 2007 Feb;5(2):282-8. doi: 10.1111/j.1538-7836.2007.02349.x. Epub 2006 Dec 7.

von Willebrand disease, type 2B: A diagnosis more elusive than previously thought.

Thromb Haemost. 2008 Mar;99(3):630-1; author reply 632-3. doi: 10.1160/TH07-12-0758.

Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.

J Thromb Haemost. 2007 Feb;5(2):321-8. doi: 10.1111/j.1538-7836.2007.02296.x. Epub 2006 Nov 1.

Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.

Acta Haematol. 2009;121(2-3):145-53. doi: 10.1159/000214855. Epub 2009 Jun 8.

The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.

J Thromb Haemost. 2006 Feb;4(2):417-25. doi: 10.1111/j.1538-7836.2006.01742.x.

Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.

Acta Haematol. 2009;121(2-3):154-66. doi: 10.1159/000214856. Epub 2009 Jun 8.

[Information on von Willebrand disease].

Rinsho Byori. 1997 Oct;45(10):942-50.

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?

Br J Haematol. 2001 Mar;112(3):578-83. doi: 10.1046/j.1365-2141.2001.02597.x.

引用本文的文献

Ratio of Von Willebrand Collagen Binding Assay and Von Willebrand Antigen Can Predict Multimer Size in Von Willebrand Disease.

Haemophilia. 2025 May;31(3):450-457. doi: 10.1111/hae.70025. Epub 2025 Mar 7.

Structure-resolved dynamics of type 2M von Willebrand disease.

J Thromb Haemost. 2025 Apr;23(4):1215-1228. doi: 10.1016/j.jtha.2024.12.026. Epub 2025 Jan 3.

New advances in the diagnosis of von Willebrand disease.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):596-600. doi: 10.1182/hematology.2019000064.

The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.

J Mol Biol. 2017 Jan 6;429(1):32-47. doi: 10.1016/j.jmb.2016.11.014. Epub 2016 Nov 24.

Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity.

Int J Lab Hematol. 2013 Apr;35(2):170-6. doi: 10.1111/ijlh.12019. Epub 2012 Oct 29.

Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.

J Thromb Haemost. 2012 May;10(5):940-50. doi: 10.1111/j.1538-7836.2012.04675.x.